Healing lives: Tuberculosis patients find strength and care in Baldia, Pakistan

“If I hadn’t known about this disease, it would have worsened. Then who knows whether treatment would have been possible?” says Muhammad Rahim, his voice low as he sits outside the consultation room at the Médecins Sans Frontières (MSF) tuberculosis (TB) clinic in the Rural Health Centre of Baldia. Nearby, his six-year-old son Mustafa swings … Read more

Uzbekistan: MSF Successfully Concludes Nukus TB Project

Nukus/ Amsterdam, 22 September 2025 – Médecins Sans Frontières (MSF), the Ministry of Health of Uzbekistan (MoH) and the Ministry of Health of Karakalpakstan today marked the successful conclusion of their long-running collaboration on the Karakalpakstan Tuberculosis Programme. The closing ceremony, attended by MSF staff, national health authorities and representatives of expert community, celebrated almost … Read more

Médecins Sans Frontières Wraps Up Tuberculosis Project in Dushanbe, Tajikistan: A Timeline of Achievements

Dushanbe, Tajikistan – As Médecins Sans Frontières (MSF) concludes its tuberculosis (TB) project in Dushanbe, Tajikistan, after 13 years of collaboration with the Ministry of Health and Social Protection of Population, we reflect on the programme’s journey. MSF’s work in Dushanbe focused on detecting TB cases through improved diagnostic techniques, tracing contacts, and treating children … Read more

Deepak Shegar: Battling DR-TB with resilience and dreams

“When I recover, I want to play cricket,” says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire for a brand-new bike, Deepak’s journey to pursue his goals has been long and challenging. … Read more

MSF reveals cost of its landmark TB clinical trial: €34 million

MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 – At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that helped identify a shorter, … Read more

Myanmar: I have defeated TB and I wish the same for other patients

Multi-drug resistant tuberculosis is one of the most complex types of tuberculosis you can get. As opposed to drug-sensitive, which responds well to the medication, multi-drug resistant tuberculosis, by its very name, is resistant to some of the drugs used to treat the disease. This makes the response more complicated, often requiring the doctors to … Read more

Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis

Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school in Chembur, Mumbai. … Read more

Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options

endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant … Read more